Applied Immunology
Summary
Applied immunology harnesses understanding of immune system mechanisms to develop diagnostics, vaccines and immune-based therapies. By dissecting innate and adaptive pathways, researchers engineer targeted interventions—including monoclonal antibodies, structure-guided antigen design, nucleic acid platforms and immunomodulatory agents—to prevent or treat infections, cancer and immune-mediated disorders. Strategies range from epitope optimisation and immune checkpoint modulation to gene-silencing technologies that reduce pathogenic antigen burden. The field also explores cellular niches and cytokine networks to restore tolerance or amplify effector responses. Integrating structural biology, molecular immunology and translational platforms, applied immunology seeks to convert basic insights into clinical solutions with global impact.
Research from Nature Portfolio
A human monoclonal antibody against the malaria circumsporozoite protein has been refined for affordable paediatric use. Derived from vaccine-elicited B-cell repertoires, this antibody confers pan-genotypic protection in preclinical models, marking a promising passive immunisation strategy. Concurrently, cryo-electron microscopy of an engineered hepatitis C virus E1E2 ectodomain in complex with broadly neutralising Fabs delineates the native glycoprotein architecture and identifies conserved epitopes. These structural insights underpin rational immunogen design for next-generation HCV vaccines that faithfully mimic the viral surface.
Research from all publishers
In a phase 2b trial, seasonal administration of a low-dose R21 protein-nanoparticle vaccine adjuvanted with Matrix-M achieved ~75% efficacy against clinical malaria in children over one year, with sustained antibody titres further boosted by a late third dose. This study highlights the practicality of protein-based vaccines in endemic settings. Separately, a multifunctional RNA interference therapy—co-delivering pan-genotypic siRNAs against HBV and interleukin-2 mRNA via lipid nanoparticles—elicited up to 3 log₁₀ reductions in viral DNA while inducing robust HBV-specific CD4+ and CD8+ T-cell responses in murine models. This combined knockdown-and-boost approach exemplifies innovative therapeutic vaccine design for chronic hepatitis B.
Applied Immunology publication trend
The graph below shows the total number of articles in applied immunology across all publications each year (not limited to Nature Index journals).
Technical terms
Neutralising antibody: An antibody that binds to a pathogen’s surface antigen to block its entry into host cells.
Cryo-electron microscopy: A technique for imaging biomolecules in vitrified specimens at near-atomic resolution.
Ectodomain: The extracellular portion of a membrane-anchored protein targeted in vaccine antigen design.
Monoclonal antibody: A homogeneous antibody derived from a single B-cell clone, with defined antigen specificity.
RNA interference (RNAi): A gene-silencing pathway in which small interfering RNAs target complementary mRNA for degradation.
Adjuvant: A component of vaccine formulations used to enhance or shape the immune response to the antigen.
References
- A candidate antibody drug for prevention of malaria. Nature Medicine (2024).
- Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies. Nature Communications (2023).
- Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. The Lancet (2021).
- Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection. Signal Transduction and Targeted Therapy (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.